ResMed (WBO:RMD) Ending Cash Position : €193 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is ResMed Ending Cash Position?

ResMed's Ending Cash Position for the quarter that ended in Dec. 2023 was €193 Mil.

ResMed's quarterly Ending Cash Position declined from Jun. 2023 (€210 Mil) to Sep. 2023 (€196 Mil) and declined from Sep. 2023 (€196 Mil) to Dec. 2023 (€193 Mil).

ResMed's annual Ending Cash Position increased from Jun. 2021 (€245 Mil) to Jun. 2022 (€259 Mil) but then declined from Jun. 2022 (€259 Mil) to Jun. 2023 (€210 Mil).

ResMed Ending Cash Position Historical Data

The historical data trend for ResMed's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Ending Cash Position Chart

ResMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

Get a 7-Day Free Trial

130.21

411.28

245.08

258.93

210.34

ResMed Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															239.02	212.85	210.34	195.93	192.80

ResMed Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

ResMed's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	252.634	+	-42.291
	=	210

ResMed's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	191.744	+	1.052
	=	193

ResMed Ending Cash Position Related Terms

Thank you for viewing the detailed overview of ResMed's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed (WBO:RMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (WBO:RMD) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA RMEA:Germany R1MD34:Brazil RMD:Australia

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.